Skip to content
Biodatica
Start free

Investigator

Laura Fejerman

UNIVERSITY OF CALIFORNIA AT DAVIS · funded by NCI

Companies
1

Resolved onto their grants.

Grants
11

Federal awards on file.

Non-dilutive funding
$2.1M

Summed across those awards.

First award
Jul 1, 2002

Latest Sep 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)

    $22k

    Sep 1, 2024NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11400940 (opens the source filing in a new tab)

  2. R01

    Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)

    $12k

    Sep 1, 2024NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11400941 (opens the source filing in a new tab)

  3. R01

    Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)

    $9k

    Sep 1, 2024NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11400937 (opens the source filing in a new tab)

  4. R01

    Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)

    $47k

    Sep 1, 2024NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11400938 (opens the source filing in a new tab)

  5. R01

    Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)

    $9k

    Sep 1, 2024NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11400939 (opens the source filing in a new tab)

  6. R01

    Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)

    $730k

    Sep 1, 2024NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11179412 (opens the source filing in a new tab)

  7. R01

    Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates

    $381k

    May 1, 2023NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11078209 (opens the source filing in a new tab)

  8. R01

    Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates

    $58k

    May 1, 2023NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11411764 (opens the source filing in a new tab)

  9. R01

    Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates

    $381k

    May 1, 2023NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11320872 (opens the source filing in a new tab)

  10. R01

    Her2 status of breast cancer in diverse populations: improving genetic prediction and understanding molecular correlates

    $58k

    May 1, 2023NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11512975 (opens the source filing in a new tab)

  11. P30

    Community Outreach and Engagement

    $409k

    Jul 1, 2002NCIUNIVERSITY OF CALIFORNIA AT DAVISNIH RePORTER · 11178769 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources